As of 2025-08-03, the Intrinsic Value of Biostem Technologies Inc (BSEM) is 93.80 USD. This BSEM valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 11.26 USD, the upside of Biostem Technologies Inc is 732.90%.
The range of the Intrinsic Value is 69.32 - 216.42 USD
Based on its market price of 11.26 USD and our intrinsic valuation, Biostem Technologies Inc (BSEM) is undervalued by 732.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (8,854.86) - (1,422.33) | (2,435.05) | -21721.6% |
| DCF (Growth 10y) | (18,301.61) - (120,340.60) | (32,200.06) | -286015.2% |
| DCF (EBITDA 5y) | 69.32 - 216.42 | 93.80 | 732.9% |
| DCF (EBITDA 10y) | 1,837.74 - 4,956.77 | 2,407.08 | 21273.3% |
| Fair Value | 9.60 - 9.60 | 9.60 | -14.78% |
| P/E | 9.64 - 14.59 | 11.32 | 0.5% |
| EV/EBITDA | 15.58 - 45.68 | 28.30 | 151.3% |
| EPV | (1.15) - (1.80) | (1.48) | -113.1% |
| DDM - Stable | 30.51 - 235.88 | 133.20 | 1082.7% |
| DDM - Multi | 235.61 - 1,416.19 | 404.09 | 3488.1% |
| Market Cap (mil) | 187.51 |
| Beta | 1.77 |
| Outstanding shares (mil) | 16.65 |
| Enterprise Value (mil) | 168.79 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.57% |
| Cost of Debt | 4.48% |
| WACC | 6.50% |